Research Article

Clinical Implications of Age in Differentiated Thyroid Cancer: Comparison of Clinical Outcomes between Children and Young Adults

Table 1

Comparison of clinicopathological characteristics among groups.

<20 years old (A) (n = 98)20–29 years old (B) (n = 1261)30–39 years old (C) (n = 4017) value (A versus B) value (A versus C)

Age (years)16.7 ± 3.026.2 ± 2.534.8 ± 2.8<0.001<0.001
Male : female1 : 7.91 : 7.21 : 5.20.8730.211
 Male11 (11.2%)153 (12.1%)650 (16.2%)
 Female87 (88.8%)1108 (87.9%)3367 (83.8%)
Tumor size (cm)2.1 ± 1.31.3 ± 1.01.0 ± 0.8<0.001<0.001
Type of carcinoma0.002<0.001
 PTC91 (92.9%)1241 (98.4%)3989 (99.3%)
 FTC7 (7.1%)20 (1.6%)28 (0.7%)
Multifocality24 (24.5%)284 (22.5%)975 (34.3%)0.6190.520
Bilaterality15 (15.3%)173 (13.7%)592 (14.7%)0.6490.885
ETE36 (36.7%)359 (28.5%)610 (15.2%)0.4020.153
T stage<0.001<0.001
 T144 (44.9%)815 (64.7%)3248 (80.9%)
 T217 (17.3%)85 (6.7%)154 (3.8%)
 T333 (33.7%)342 (27.1%)558 (13.9%)
 T44 (4.1%)19 (1.5%)57 (1.4%)
N stage<0.001<0.001
 N025 (25.5%)577 (45.8%)2255 (56.2%)
 N1a43 (43.9%)454 (36.0%)1331 (33.1%)
 N1b30 (30.6%)230 (18.2%)431 (10.7%)
M stage0.0640.018
 M12 (2.0%)4 (0.3%)7 (0.2%)
Recurrence14 (14.3%)83 (6.6%)121 (3.0%)0.004<0.001

Data are expressed as patient’s number (%) or mean ± SD. A statistically significant difference was defined as . PTC, papillary thyroid carcinoma; FTC, follicular thyroid carcinoma; ETE, extrathyroidal extension; T, tumor; N, node; M, metastasis.